Pages that link to "Q67920810"
Jump to navigation
Jump to search
The following pages link to Interstitial hypertension in human breast and colorectal tumors (Q67920810):
Displaying 50 items.
- Pathophysiological Basis for the Formation of the Tumor Microenvironment (Q26752406) (← links)
- Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? (Q26999332) (← links)
- Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective. (Q28073956) (← links)
- Modulation of invasive phenotype by interstitial pressure-driven convection in aggregates of human breast cancer cells (Q28483818) (← links)
- Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948) (Q28732214) (← links)
- Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma (Q29616287) (← links)
- Subharmonic aided pressure estimation for monitoring interstitial fluid pressure in tumours--in vitro and in vivo proof of concept (Q30404198) (← links)
- Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. (Q30469815) (← links)
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases (Q30471456) (← links)
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors (Q30525290) (← links)
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers (Q30542073) (← links)
- Non-invasive imaging of barriers to drug delivery in tumors (Q31163579) (← links)
- Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours (Q33313523) (← links)
- Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors (Q33416674) (← links)
- Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma (Q33519161) (← links)
- In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer (Q33605281) (← links)
- Frontiers in cancer nanomedicine: directing mass transport through biological barriers (Q33746335) (← links)
- A numerical framework for interstitial fluid pressure imaging in poroelastic MRE. (Q33769107) (← links)
- The role of mechanical forces in tumor growth and therapy (Q33942378) (← links)
- Multi-stage delivery nano-particle systems for therapeutic applications (Q34166491) (← links)
- Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib (Q34294361) (← links)
- High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts (Q34328523) (← links)
- Delivering nanomedicine to solid tumors (Q34726981) (← links)
- Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules (Q35067308) (← links)
- Increased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC-β. (Q35806374) (← links)
- Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis (Q35810928) (← links)
- Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis (Q35855622) (← links)
- Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline (Q35978386) (← links)
- Imatinib mesylate and its potential implications for gynecologic cancers (Q36046233) (← links)
- Interstitial fluid pressure in intracranial tumours in patients and in rodents (Q36116465) (← links)
- Design considerations for nanotherapeutics in oncology (Q36236848) (← links)
- Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model (Q36240366) (← links)
- Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients. (Q36306066) (← links)
- SiRNA-mediated reduction of alpha-actinin-1 inhibits pressure-induced murine tumor cell wound implantation and enhances tumor-free survival (Q36485279) (← links)
- Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. (Q36557915) (← links)
- Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug (Q36619067) (← links)
- Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin (Q36689267) (← links)
- Proton relaxation times and interstitial fluid pressure in human melanoma xenografts (Q36843901) (← links)
- Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789 (Q37086489) (← links)
- Multistage nanoparticles for improved delivery into tumor tissue (Q37176313) (← links)
- The tumor microenvironment and metastatic disease (Q37187529) (← links)
- Application of prolonged microdialysis sampling in carboplatin-treated cancer patients (Q37215307) (← links)
- Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients (Q37382835) (← links)
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles (Q37476252) (← links)
- Dynamic CT imaging of volumetric changes in pulmonary nodules correlates with physical measurements of stiffness. (Q37656819) (← links)
- Nanopreparations to overcome multidrug resistance in cancer (Q38131264) (← links)
- Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model (Q38245841) (← links)
- Pressure activates colon cancer cell adhesion via paxillin phosphorylation, Crk, Cas, and Rac1. (Q38579028) (← links)
- Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip (Q38674749) (← links)
- Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment (Q38685276) (← links)